165 related articles for article (PubMed ID: 33065789)
1. Clinical value of N-acetylcysteine combined with terbutaline sulfate in elderly patients with chronic obstructive pulmonary disease and its effect on apoptosis/anti-apoptosis mechanism.
Zhou Q; Zhang L; Sun Y; Xie M; Lin J
Ann Palliat Med; 2020 Sep; 9(5):3393-3401. PubMed ID: 33065789
[TBL] [Abstract][Full Text] [Related]
2. Update on the pathological processes, molecular biology, and clinical utility of N-acetylcysteine in chronic obstructive pulmonary disease.
Tse HN; Tseng CZ
Int J Chron Obstruct Pulmon Dis; 2014; 9():825-36. PubMed ID: 25125976
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress and respiratory system: pharmacological and clinical reappraisal of N-acetylcysteine.
Santus P; Corsico A; Solidoro P; Braido F; Di Marco F; Scichilone N
COPD; 2014 Dec; 11(6):705-17. PubMed ID: 24787454
[TBL] [Abstract][Full Text] [Related]
4. Oral N-acetylcysteine attenuates pulmonary emphysema and alveolar septal cell apoptosis in smoking-induced COPD in rats.
Cai S; Chen P; Zhang C; Chen JB; Wu J
Respirology; 2009 Apr; 14(3):354-9. PubMed ID: 19341424
[TBL] [Abstract][Full Text] [Related]
5. Effect of high-dose N-acetylcysteine on airway geometry, inflammation, and oxidative stress in COPD patients.
De Backer J; Vos W; Van Holsbeke C; Vinchurkar S; Claes R; Parizel PM; De Backer W
Int J Chron Obstruct Pulmon Dis; 2013; 8():569-79. PubMed ID: 24293993
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological investigation on the anti-oxidant and anti-inflammatory activity of N-acetylcysteine in an ex vivo model of COPD exacerbation.
Cazzola M; Calzetta L; Facciolo F; Rogliani P; Matera MG
Respir Res; 2017 Jan; 18(1):26. PubMed ID: 28118826
[TBL] [Abstract][Full Text] [Related]
7. The role of preconditioning and N-acetylcysteine on oxidative stress resulting from tourniquet-induced ischemia-reperfusion in arthroscopic knee surgery.
Koca K; Yurttas Y; Cayci T; Bilgic S; Kaldirim U; Durusu M; Cekli Y; Ozkan H; Hanci V; Purtuloglu T; Akgul EO; Oguz E; Yildiz C; Basbozkurt M
J Trauma; 2011 Mar; 70(3):717-23. PubMed ID: 21610364
[TBL] [Abstract][Full Text] [Related]
8. Oral
Hirai DM; Jones JH; Zelt JT; da Silva ML; Bentley RF; Edgett BA; Gurd BJ; Tschakovsky ME; O'Donnell DE; Neder JA
J Appl Physiol (1985); 2017 May; 122(5):1351-1361. PubMed ID: 28255088
[TBL] [Abstract][Full Text] [Related]
9. Effect of doxycyline in chronic obstructive pulmonary disease - An exploratory study.
Singh B; Ghosh N; Saha D; Sarkar S; Bhattacharyya P; Chaudhury K
Pulm Pharmacol Ther; 2019 Oct; 58():101831. PubMed ID: 31349003
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress and antioxidant enzyme activity in South Indian male smokers with chronic obstructive pulmonary disease.
Arja C; Surapaneni KM; Raya P; Adimoolam C; Balisetty B; Kanala KR
Respirology; 2013 Oct; 18(7):1069-75. PubMed ID: 23683270
[TBL] [Abstract][Full Text] [Related]
11. Antioxidant enzymes and melatonin levels in patients with bronchial asthma and chronic obstructive pulmonary disease during stable and exacerbation periods.
Gumral N; Naziroglu M; Ongel K; Beydilli ED; Ozguner F; Sutcu R; Caliskan S; Akkaya A
Cell Biochem Funct; 2009 Jul; 27(5):276-83. PubMed ID: 19475625
[TBL] [Abstract][Full Text] [Related]
12. The effect of N-acetylcysteine on exacerbations of chronic obstructive pulmonary disease: A meta-analysis and systematic review.
Fowdar K; Chen H; He Z; Zhang J; Zhong X; Zhang J; Li M; Bai J
Heart Lung; 2017; 46(2):120-128. PubMed ID: 28109565
[TBL] [Abstract][Full Text] [Related]
13. The effect of alogliptin on pulmonary function in obese patients with type 2 diabetes inadequately controlled by metformin monotherapy.
Tai H; Wang MY; Zhao YP; Li LB; Dong QY; Liu XG; Kuang JS
Medicine (Baltimore); 2016 Aug; 95(33):e4541. PubMed ID: 27537577
[TBL] [Abstract][Full Text] [Related]
14. An increase of soluble Fas, an inhibitor of apoptosis, associated with progression of COPD.
Yasuda N; Gotoh K; Minatoguchi S; Asano K; Nishigaki K; Nomura M; Ohno A; Watanabe M; Sano H; Kumada H; Sawa T; Fujiwara H
Respir Med; 1998 Aug; 92(8):993-9. PubMed ID: 9893764
[TBL] [Abstract][Full Text] [Related]
15. [Assessment of the hemodynamics of pulmonary artery and right ventricular function in chronic obstructive pulmonary disease with pulmonary hypertension using cardiac magnetic resonance imaging].
Fan Y; Guo X; Sun X; Cao X; He J; Zhu L; Chen J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Aug; 31(8):972-977. PubMed ID: 31537222
[TBL] [Abstract][Full Text] [Related]
16. Oxidation pathway and exacerbations in COPD: the role of NAC.
Matera MG; Calzetta L; Cazzola M
Expert Rev Respir Med; 2016; 10(1):89-97. PubMed ID: 26567752
[TBL] [Abstract][Full Text] [Related]
17. N-Acetylcysteine protects human bronchi by modulating the release of neurokinin A in an ex vivo model of COPD exacerbation.
Calzetta L; Rogliani P; Facciolo F; Rinaldi B; Cazzola M; Matera MG
Biomed Pharmacother; 2018 Jul; 103():1-8. PubMed ID: 29635121
[TBL] [Abstract][Full Text] [Related]
18. The effect of different treatment modalities on oxidative stress in COPD.
Kuleci S; Hanta I; Kocabas A; Canacankatan N
Adv Ther; 2008 Jul; 25(7):710-7. PubMed ID: 18592146
[TBL] [Abstract][Full Text] [Related]
19. Effect of oral N-acetylcysteine on COPD patients with microsatellite polymorphism in the heme oxygenase-1 gene promoter.
Zhang JQ; Zhang JQ; Fang LZ; Liu L; Fu WP; Dai LM
Drug Des Devel Ther; 2015; 9():6379-87. PubMed ID: 26674585
[TBL] [Abstract][Full Text] [Related]
20. Xinfeng capsule improves pulmonary function in ankylosing spondylitis patients via NF-ΚB-iNOS-NO signaling pathway.
Liu J; Qi Y; Zheng L; Cao Y; Wan L; Ye W; Fang L
J Tradit Chin Med; 2014 Dec; 34(6):657-65. PubMed ID: 25618969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
